Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Bo Nordén"'
Autor:
Josefine Sandström, Jens Bomanson, Gizeh Pérez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindström, Olle Stål
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract GATA binding protein 3 (GATA3) is essential for normal development of the mammary gland and associated with ER-positive breast cancer. Loss of GATA3 has been associated with epithelial-mesenchymal transition (EMT) in experimental studies. We
Externí odkaz:
https://doaj.org/article/5489900ba9c54810a4ba6d86094baf2b
Autor:
Helena Fohlin, Anna Nordenskjöld, Johan Rosell, Mårten Fernö, Tommy Fornander, Lisa Rydén, Lambert Skoog, Bo Nordenskjöld, Olle Stål
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Hormone receptor positivity predicts benefit from endocrine therapy but the knowledge about the long-term survival of patients with different tumor receptor levels is limited. In this study, we describe the 25 years outcome of tamoxifen (
Externí odkaz:
https://doaj.org/article/70fb0a9414d446158f65dbae4436b48e
Autor:
Terese Engström, Maria Ekholm, Mårten Fernö, Christine Lundgren, Bo Nordenskjöld, Olle Stål, Pär-Ola Bendahl, Julia Tutzauer, Lisa Rydén
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
ABSTRACT Background and purpose: Tamoxifen remains an important adjuvant treatment in premenopausal patients with hormone receptor-positive breast cancer. Thus, determination of hormone receptors is important. Here, we compare cytosol-based methods,
Externí odkaz:
https://doaj.org/article/3af36158a1dc4d0f99ce91c65e6aa575
Autor:
Anna Nordenskjöld, Helena Fohlin, Johan Rosell, Nils-Olof Bengtsson, Tommy Fornander, Thomas Hatschek, Henrik Lindman, Per Malmström, Lisa Rydén, Arne Wallgren, Olle Stål, Bo Nordenskjöld
Publikováno v:
Breast, Vol 71, Iss , Pp 63-68 (2023)
Background: Tamoxifen is an established treatment for breast cancer, but its long-term effects on survival and on secondary cancers are not fully evaluated. Material and methods: We studied 30 years outcome of 4124 postmenopausal patients who were ra
Externí odkaz:
https://doaj.org/article/487528a90ae34cc4bee6e74d37bc5e34
Autor:
Christine Lundgren, Julia Tutzauer, Sarah E. Church, Olle Stål, Maria Ekholm, Carina Forsare, Bo Nordenskjöld, Mårten Fernö, Pär-Ola Bendahl, Lisa Rydén
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-20 (2023)
Abstract Background Gene expression (GEX) signatures in breast cancer provide prognostic information, but little is known about their predictive value for tamoxifen treatment. We examined the tamoxifen-predictive value and prognostic effects of diffe
Externí odkaz:
https://doaj.org/article/f09fa8d43985469ab9231f4bffcde4a9
Autor:
Lena Börjesson, Håkan Bladh, Didier Rognan, Chris de Graaf, Tero Linnanen, Annea Lisius, Hazel Joan Dyke, Malena Bengtsson, Marco van den Heuvel, Igor L. Shamovsky, Bo-Göran Josefsson, Bo Nordén, Anna Kristoffersson, Marco Skrinjar, Henrik Johansson, Lena Ripa, Stephen Connolly, Roope Männikkö, Klaus Urbahns, Lisa Alderin, Alexander Rosendahl, Steve Price
Publikováno v:
Shamovsky, I, de Graaf, C, Alderin, L, Bengtsson, M, Bladh, H, Borjesson, L, Connolly, S, Dyke, H J, van den Heuvel, M, Johansson, H, Josefsson, B G, Kristoffersson, A, Linnanen, T, Lisius, A, Mannikko, R, Norden, B, Price, S, Ripa, L, Rognan, D, Rosendahl, A, Skrinjar, M & Urbahns, K 2009, ' Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites ', Journal of Medicinal Chemistry, vol. 52, no. 23, pp. 7706-23 . https://doi.org/10.1021/jm900713y
Journal of Medicinal Chemistry, 52(23), 7706-23. American Chemical Society
Journal of Medicinal Chemistry, 52(23), 7706-23. American Chemical Society
The metabolic stability and selectivity of a series of CCR8 antagonists against binding to the hERGion channel and cytochrome Cyp2D6 are studied by principal component analysis. It is demonstrated that an efficient way of increasing metabolic stabili
Autor:
Christine Lundgren, Pär-Ola Bendahl, Sarah E. Church, Maria Ekholm, Mårten Fernö, Carina Forsare, Ute Krüger, Bo Nordenskjöld, Olle Stål, Lisa Rydén
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract PAM50 intrinsic subtyping and risk of recurrence (ROR) score are approved for risk profiling in postmenopausal women. We aimed to examine their long-term prognostic value in terms of breast cancer-free interval (BCFi) and overall survival (O
Externí odkaz:
https://doaj.org/article/6ac42a655e1c44b8aaf372ca6538233d
Autor:
Per Brunmark, Bo Nordén, Hans Lennernäs, Ann-Britt Jeppsson, Elisabeth Nilsson, Ursula Hultkvist Bengtsson, Ann Tronde
Publikováno v:
Journal of Drug Targeting. 11:61-74
The pulmonary absorption of nine low-molecular-weight (225-430 Da) drugs (atenolol, budesonide, enalaprilat, enalapril, formoterol, losartan, metoprolol, propranolol and terbutaline) and one high-molecular-weight membrane permeability marker compound
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:4738-4740
A class of inhibitors of mitogen activated protein kinase-activated kinase 2 (MK2) was discovered via high-throughput screening. This compound class demonstrates activity against the enzyme with sub-microM IC(50) values, and suppresses LPS-induced TN
Autor:
Nina Kann, David J. Keeling, Bo Nordén, Vladimir Shcherbukhin, Jan P. Mattsson, Karin M Edvinsson, Patrik Holm, Margareta Herslöf
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 10:503-507
Unsymmetrical diamide libraries have been prepared by a general and versatile solid phase route, using diacid templates in combination with aromatic and aliphatic amines chosen with the help of statistical experimental design. The compounds were test